ClinicalTrials.gg
RecruitingNCT06416917Updated May 16, 2024

Glenohumeral Internal Rotation Deficit Among Professional Athletes

An observational study in Internal Rotation Contracture-shoulder, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-16.

Sponsored by Cairo University · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
70
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The study aimed to identify the prevalence of GIRD among elite Egyptian volleyball players in selected clubs in Egypt.

Read the detailed description

Volleyball is a highly technical sport that involves powerful overhead movements performed repetitively. The volleyball attack "spike," is a complex overhead movement that professional players perform up to 40,000 times a year (Kugler, 1996). It consists of four phases: windup, cocking, acceleration, and deceleration (follow-through). The windup phase is the arm is elevated to a position that is more than 90° from the anatomical position and the shoulder is slightly horizontally abducted. The cocking phase is abduction and external rotation (ER) reach their maximum levels. The acceleration phase is the shoulder rapidly internally rotates and adducts the arm up to the point where the hand strikes the ball (shoulder abducted at 140°-170° in neutral rotation. The deceleration (follow-through) phase extend from ball impact until the arm finally stops on the side of the trunk (Seminati et al., 2015).

The shoulder complex has the widest multi-planar range of motion (ROM), it is a frequently injured body part in volleyball (12%-18%), mainly due to overuse mechanisms (Agel et al., 2007; Clarsen et al., 2015; Cuñado-González et al., 2019). Shoulder injuries are the third-most common volleyball injury (Reeser et al., 2010), According to reports, between (15- 23%) of volleyball players experience shoulder pain or injuries during a season (Clarsen et al., 2015; Cuñado-González et al., 2019; Forthomme et al., 2013). As a result, shoulder injuries are the most common reason for missing volleyball matches and practices (Hao et al., 2019).

Glenohumeral internal rotation deficit (GIRD) is an adaptive process in which the throwing shoulder has a loss of internal rotation (IR) ROM (Rose \& Noonan, 2018). The anatomical GIRD is a typical response in overhead athletes with a lowered IR of about 18̊ to 20⁰ and symmetry in the total rotation motion (TRM), while Pathologic GIRD was identified in athletes with an IR deficit greater than 18⁰ and a TRM difference of more than 5⁰ between the shoulders. Not all cases of GIRD are indicative of pathology (Manske et al., 2013).

It has been reported that GIRD can be seen in athletes who play softball, tennis, handball, football, baseball and even javelin throwers (Mlynarek \& Lee, 2017). Most of the studies are involved in baseball players, while volleyball and other overhead sports are known to have different throwing kinematics (Reeser et al., 2010). It has been shown that asymptomatic overhead athletes have GIRD at 10-15° whereas symptomatic overhead athletes have GIRD at 19-25° (Kaplan et al., 2011; Myers et al., 2006; Trakis et al., 2008). A higher degree of GIRD was found in the pain group than the no-pain group on symptomatic and asymptomatic handball and tennis players (Almeida et al., 2013; Moreno-Pérez et al., 2015). However, Lubiatowski et al., (2018) found only eleven out of eighty-seven handball players exhibited GIRD, although the author did not account for GIRD unless it reached 20-25°. Ellenbecker et al., (2002) have reported decreases of 5-10 ⁰ on average in the dominant arm TRM parameter in uninjured elite-level tennis players. Regarding volleyball, some authors found that few asymptomatic volleyball players displayed GIRD, but unless a player had a GIRD of > 18°, they did not consider them to have GIRD (Harput et al., 2016; Saccol et al., 2016).

Mizoguchi et al., (2022) studied (123 male and female) of adolescent (15 to 17 years old) volleyball players in Japan and found 38.2% had GIRD and decreased TRM in their shoulders. The GIRD group had an intrinsic external rotation deficiency (ERD) that was unrelated to sex, body composition, a history of shoulder injuries, years of volleyball experience, practice time, or court position. There were sex-specific differences in shoulder ROM, especially in the external rotation (ER) and IR ROM, with males being hypomobile and females being hypermobile. These results find agreement with (Harput et al., 2016) who found that 38.5% of adolescent volleyball players had GIRD with decreased TRM. Reeser et al., (2010) discovered a significant GIRD (8.9°), a non-significant presence of external rotation gain (ERG) (2°), and no change in TRM. It was reported in literature that There is still much to learn about the connection between volleyball players' shoulder pain and GIRD, so more research is required (Schmalzl et al., 2022; Harput et al., 2016).

It was found that GIRD is often present in adult volleyball players (Schmalzl et al., 2022), but this may not be related to shoulder pain or injury, but imbalances in muscle strength around the shoulder can affect pain or injury (challoumas et al., 2017). The offensive players of volleyball players have a GIRD of ≥10 ⁰ and a lower TRM are linked to a higher prevalence of posterior-superior impingement (Schmalzl et al., 2022).

Alqarni et al., (2022) showed that GIRD was present in pain group and no pain group. The pain group exhibited higher degrees of GIRD (15.65°) than the no pain group (9.06°). The results also revealed that the pain group exhibited a higher difference in TRM (16.17°) than the no pain group (10.17°).

Players of volleyball may have changes in glenohumeral (GH) joint mobility and flexibility as a result of their sport-related activities (Harput et al., 2016; Keller et al., 2018; Wilk et al., 2011; Burkhart et al., 2003). They commonly perform spiking and serving (Reeser et al., 2010), which causes the shoulder joint to modify its bony and soft tissue structures. This results in 8-20% of all volleyball players' injuries (Reeser et al., 2010). Deceleration might result in repeated microtrauma as a consequence of the alteration in shoulder biomechanics during throwing exercises. This adaptation is essential for performance, yet it can also be a risk factor for injuries, leading to questions about how much of this deficit can be tolerated before clinical intervention is required (Whiteley \& Oceguera, 2016).

In summary, GIRD is a common condition in volleyball players. It is not always associated with pain or injury, but it can be a risk factor for posterior-superior impingement. Up to author knowledge, there is no published study regarding the prevalence of GIRD among professional Egyptian volleyball players.

02

Conditions studied

  • Internal Rotation Contracture-shoulder

Browse trials for

Keywords

  • GIRD
03

In context

Contracture

79 studies on the registry are indexed under Contracture; 18 are open to participants now.

This study's planned enrollment of 70 is below the median of 150 across 13 observational studies indexed under Contracture.

Browse Contracture studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

professional volleyball athletes from 18 to 30 years old.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. A professional volleyball Egyptian athlete who are playing in the selected clubs around Egypt; the four clubs in Alexandria (Smouha sporting club, Alex sporting club, Ittihad club and Horse owners club) and the three clubs in Cairo (Egyptian shooting club, wadi degla club, Zamalek club).

      1. Elite Male and female volleyball players with between (18.5 to 24.9) kg/m².
      1. Their age range is between 14 to 30 years old

Exclusion criteria

Exclusion Criteria:

    1. Athletes who have a history of shoulder surgery or injury such as rotator cuff tear or labrum tear.

      1. Athletes who have a history of injuries (fractures, dislocations) or surgeries in other joints of the upper limb (elbow, forearm, wrist, and hand) (Dabhokar et al., 2018).
      1. Athletes who have a history of inflammatory joint disease, or neurological disorders that could affect their shoulder ROM such as arthritis or diabetes (Dabhokar et al., 2018).
      1. Athletes who are taking any medications that could affect their shoulder ROM or pain.
      1. Athletes who are currently inactive at the professional level due to multiple injuries that have prevented them from practicing.
      1. Athletes who have been diagnosed with kyphosis and scoliosis in the shoulder and thoracic regions, as well as other anatomical anomalies (pennella et al., 2022).
      1. Athletes who have experienced shoulder pain with stomach discomfort (pennella et al., 2022)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • Devicebubble inclinometer

    to measure range of motion

06

What researchers measure

Primary outcomes

  1. internal rotation, external rotation and total range of motion

    shoulder range of motion

    Time frame: 4 months

  2. physical performance

    questionnaire

    Time frame: 4 months

  3. pain intensity

    visual analog scale

    Time frame: 4 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2024; primary completion for Sep 2024, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 12, 2024
First posted
May 16, 2024
StartEst.
Jun 1, 2024
Primary completionEst.
Sep 29, 2024
CompletionEst.
Oct 30, 2024
Last update
May 16, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06416917
Lead sponsor
Cairo University
Responsible party
Hadeel Ibrahim Ali (assistant lecturer, Cairo University) — Principal investigator
First posted
May 16, 2024
Start date
Jun 1, 2024 (estimated)
Primary completion
Sep 29, 2024 (estimated)
Completion
Oct 30, 2024 (estimated)
Last update
May 16, 2024

Study contacts

hadeel I ali, master
Contact
hadeelibrahim241@gmail.com
01148321112 ext. +20

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion